Impactiviti Daily 032910 posted on March 29, 2010***** TODAY’S NEWS Antisoma/Novartis experimental drug hits the proverbial wall on Phase III lung cancer trial. Study halted. New test may predict which MS patients will most benefit from beta …Continue Reading about Impactiviti Daily 032910 →